Bionet-Asia

bionet-asia co. ltd is a vaccine company focused on technological innovation and market access. with a global market reach and network expertise, bionet has created several strategic alliances fostering vaccine self-reliance leading to the production and supply of billions of doses of vaccines on all continents. in its state-of-the-art vaccine plant in thailand, bionet is also building a unique expertise in genetic engineering, protein conjugation, cell-culture and vaccine formulation. the company has developed a broad pipeline with ten products in r&d and clinical stages, including vaccines and recombinant proteins such as crm197 protein carrier, dengue and hepatitis b vaccines. the company has transferred the technology to produce hib meningitis vaccine which is now commercialized as a pentavalent vaccine in asia. bionet has recently filed a patent application for its new recombinant acellular pertussis vaccine which is now evaluated in clinical trial. bionet is uniquely position